McCourt Janice 4
4 · Comera Life Sciences Holdings, Inc. · Filed Nov 9, 2022
Insider Transaction Report
Form 4
McCourt Janice
Chief Business Officer
Transactions
- Award
Stock Option (Right to Purchase)
2022-11-08+150,000→ 150,000 totalExercise: $1.36Exp: 2032-11-08→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The stock option shall vest over four (4) years, with twenty-five percent (25%) of the shares of Common Stock underlying the option vesting on November 1, 2023 and the remainder vesting in equal monthly installments thereafter.